Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FR12L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,234
Award facts
- Contract value 100% obligated
- $72,233.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $72,233.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units), a combination maintenance medication for chronic obstructive pulmonary disease. This non-set-aside award, with an ultimate completion date of January 23, 2026, represents a single delivery order executed from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate offices as a subsidiary of parent company Cencora, Inc.
This delivery order falls under AmerisourceBergen's substantial $999,999,999 indefinite delivery contract with DLA Troop Support Medical (designation SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen maintains a critical role in the Defense Health Agency's medical supply chain, regularly fulfilling federal procurement requirements for specialty medications, brand-name and generic pharmaceuticals, and medical supplies across multiple therapeutic domains. The contract's firm fixed-price structure and non-competitive set-aside status reflect AmerisourceBergen's established capability to meet federal medical procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DR26FR12L?
SPE2DR26FR12L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FR12L worth?
The government has obligated $72,234 on SPE2DR26FR12L.
Is contract SPE2DR26FR12L an order under another contract?
Yes. SPE2DR26FR12L is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR12L competed?
The extent of competition for SPE2DR26FR12L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award